|
C1ORF83 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.020650E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.457300E-03 |
| Normal-vs-Stage2 |
8.719900E-03 |
| Normal-vs-Stage3 |
2.84900000258048E-08 |
| Normal-vs-Stage4 |
5.17789999987528E-07 |
| Stage1-vs-Stage2 |
2.168400E-01 |
| Stage1-vs-Stage3 |
5.54520000000114E-05 |
| Stage1-vs-Stage4 |
7.847100E-04 |
| Stage2-vs-Stage3 |
2.091800E-01 |
| Stage2-vs-Stage4 |
2.953200E-01 |
| Stage3-vs-Stage4 |
8.040400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.188900E-04 |
| Normal-vs-AfricanAmerican |
1.039580E-04 |
| Normal-vs-Asian |
2.314800E-01 |
| Caucasian-vs-AfricanAmerican |
1.708840E-01 |
| Caucasian-vs-Asian |
1.357890E-02 |
| AfricanAmerican-vs-Asian |
1.168380E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.94879999999964E-05 |
| Normal-vs-Female |
5.71059999999735E-05 |
| Male-vs-Female |
7.308200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.759060E-03 |
| Normal-vs-Age(41-60Yrs) |
2.724000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.54360999999881E-05 |
| Normal-vs-Age(81-100Yrs) |
2.423700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.342200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.243400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.070600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.941600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.891800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.321600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.492600E-01 |
| Normal-vs-Grade 2 |
1.570290E-02 |
| Normal-vs-Grade 3 |
1.31390000002174E-06 |
| Normal-vs-Grade 4 |
3.53750000403608E-08 |
| Grade 1-vs-Grade 2 |
2.005600E-01 |
| Grade 1-vs-Grade 3 |
8.580700E-03 |
| Grade 1-vs-Grade 4 |
5.812200E-04 |
| Grade 2-vs-Grade 3 |
1.916380E-03 |
| Grade 2-vs-Grade 4 |
7.8744000000075E-05 |
| Grade 3-vs-Grade 4 |
1.401210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.984400E-02 |
| Normal-vs-ccB subtype |
1.80725999999742E-05 |
| ccA subtype-vs-ccB subtype |
7.223400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38119999999409E-05 |
| Normal-vs-N1 |
5.686400E-02 |
| N0-vs-N1 |
9.425400E-01 |
|
|
